Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opioids
MedTech
FDA approves first DNA test for opioid use disorder risks
Developed by AutoGenomics and sponsored by SOLVD Health, the AvertD test received an agency greenlight under very narrow conditions.
Conor Hale
Dec 21, 2023 10:18am
Click, Indivior to make digital therapeutics for addiction
Sep 8, 2023 1:13pm
FDA clears Masimo’s opioid overdose prevention monitor
Apr 3, 2023 9:31am
Eagle swoops down to nab chunk of BARDA-backed Enalare
Aug 9, 2022 11:22am
Dissolving, nerve-cooling device offers drug-free pain relief
Jul 1, 2022 10:22am
Will addiction tech curb soaring opioid overdose deaths?
Mar 21, 2022 9:15am